(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of G0S2 mRNA CTD PMID:36331819 (2,4,5-trichlorophenoxy)acetic acid decreases expression EXP 6480464 2 more ... CTD PMID:18579281 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of G0S2 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1311675 6480464 o, p'-DDT results in increased expression of G0S2 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1604363 6480464 o, p'-DDT results in increased expression of G0S2 mRNA CTD PMID:19371625 1-naphthyl isothiocyanate decreases expression ISO RGD:1311675 6480464 1-Naphthylisothiocyanate results in decreased expression of G0S2 mRNA CTD PMID:25380136 , PMID:30723492 1-nitropyrene increases expression ISO RGD:1604363 6480464 1-nitropyrene results in increased expression of G0S2 mRNA CTD PMID:19041380 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of G0S2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol affects expression ISO RGD:1604363 6480464 Ethinyl Estradiol affects the expression of G0S2 mRNA CTD PMID:26865667 17alpha-ethynylestradiol increases expression ISO RGD:1311675 6480464 Ethinyl Estradiol results in increased expression of G0S2 mRNA CTD PMID:24096037 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of G0S2 mRNA CTD PMID:17942748 , PMID:24096037 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of G0S2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1604363 6480464 Estradiol results in decreased expression of G0S2 mRNA CTD PMID:20106945 17beta-estradiol decreases expression ISO RGD:1311675 6480464 Estradiol results in decreased expression of G0S2 mRNA CTD PMID:35192832 17beta-estradiol multiple interactions ISO RGD:1311675 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of G0S2 mRNA CTD PMID:32741896 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of G0S2 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:1604363 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of G0S2 mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of G0S2 mRNA CTD PMID:20660070 , PMID:30165855 17beta-estradiol increases expression ISO RGD:1604363 6480464 Estradiol results in increased expression of G0S2 mRNA CTD PMID:23019147 17beta-estradiol 3-benzoate multiple interactions ISO RGD:1311675 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of G0S2 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of G0S2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of G0S2 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1311675 6480464 Tetrachlorodibenzodioxin results in increased expression of G0S2 mRNA CTD PMID:26232522 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1604363 6480464 Tetrachlorodibenzodioxin results in increased expression of G0S2 mRNA CTD PMID:17555868 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of G0S2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1311675 6480464 Tetrachlorodibenzodioxin affects the expression of G0S2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of G0S2 mRNA CTD PMID:17942748 more ... 2-hydroxypropanoic acid increases expression ISO RGD:1604363 6480464 Lactic Acid results in increased expression of G0S2 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1311675 6480464 3 more ... CTD PMID:20959002 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1604363 6480464 tetrabromobisphenol A results in increased expression of G0S2 mRNA CTD PMID:33476716 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of G0S2 mRNA CTD PMID:20188158 3,7-dihydropurine-6-thione increases expression ISO RGD:1311675 6480464 Mercaptopurine results in increased expression of G0S2 mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of G0S2 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression ISO RGD:1311675 6480464 1, 2-dithiol-3-thione results in increased expression of G0S2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1311675 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of G0S2 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of G0S2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1604363 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of G0S2 mRNA CTD PMID:27685785 , PMID:34831106 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of G0S2 mRNA CTD PMID:33297965 5-fluorouracil increases expression ISO RGD:1604363 6480464 Fluorouracil results in increased expression of G0S2 protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:1604363 6480464 G0S2 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 6-propyl-2-thiouracil decreases expression ISO RGD:1311675 6480464 Propylthiouracil results in decreased expression of G0S2 mRNA CTD PMID:24780913 acetylsalicylic acid increases expression ISO RGD:1311675 6480464 Aspirin results in increased expression of G0S2 mRNA CTD PMID:12800193 aflatoxin B1 affects expression ISO RGD:1604363 6480464 Aflatoxin B1 affects the expression of G0S2 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1311675 6480464 Aflatoxin B1 results in decreased expression of G0S2 mRNA CTD PMID:25378103 aflatoxin B1 decreases expression ISO RGD:1604363 6480464 Aflatoxin B1 results in decreased expression of G0S2 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of G0S2 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1604363 6480464 Tretinoin results in increased expression of G0S2 mRNA, Tretinoin results in increased expression of G0S2 protein CTD PMID:17218384 more ... amphetamine increases expression ISO RGD:1311675 6480464 Amphetamine results in increased expression of G0S2 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:1604363 6480464 aristolochic acid I results in increased expression of G0S2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1604363 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of G0S2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1604363 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of G0S2 mRNA CTD PMID:32525701 arsenite(3-) decreases expression ISO RGD:1604363 6480464 arsenite results in decreased expression of G0S2 mRNA CTD PMID:19716837 arsenite(3-) multiple interactions ISO RGD:1604363 6480464 arsenite promotes the reaction [G3BP1 protein binds to G0S2 mRNA] CTD PMID:32406909 arsenite(3-) increases methylation ISO RGD:1604363 6480464 arsenite results in increased methylation of G0S2 promoter CTD PMID:19716837 , PMID:23974009 arsenous acid increases expression ISO RGD:1604363 6480464 Arsenic Trioxide results in increased expression of G0S2 mRNA CTD PMID:29633893 benzo[a]pyrene decreases expression ISO RGD:1604363 6480464 Benzo(a)pyrene results in decreased expression of G0S2 mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1604363 6480464 Benzo(a)pyrene results in increased methylation of G0S2 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of G0S2 mRNA CTD PMID:20127859 benzo[a]pyrene increases expression ISO RGD:1604363 6480464 Benzo(a)pyrene results in increased expression of G0S2 mRNA CTD PMID:15808406 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1604363 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone multiple interactions ISO RGD:1311675 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of G0S2 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of G0S2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1604363 6480464 Diethylhexyl Phthalate results in increased expression of G0S2 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1604363 6480464 bisphenol A affects the expression of G0S2 mRNA CTD PMID:20170705 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of G0S2 mRNA, bisphenol A results in increased expression of G0S2 protein CTD PMID:32156529 , PMID:35341816 bisphenol A decreases expression ISO RGD:1311675 6480464 bisphenol A results in decreased expression of G0S2 mRNA CTD PMID:35192832 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of G0S2 mRNA CTD PMID:35341816 bisphenol A affects expression ISO RGD:1311675 6480464 bisphenol A affects the expression of G0S2 mRNA CTD PMID:30903817 bisphenol A increases methylation ISO RGD:1311675 6480464 bisphenol A results in increased methylation of G0S2 gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:1604363 6480464 bisphenol A results in decreased expression of G0S2 mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:1604363 6480464 bisphenol A results in increased expression of G0S2 mRNA CTD PMID:19371625 more ... bisphenol A increases expression ISO RGD:1311675 6480464 bisphenol A results in increased expression of G0S2 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1604363 6480464 bisphenol F results in increased expression of G0S2 mRNA CTD PMID:34831106 bosentan affects expression ISO RGD:1604363 6480464 Bosentan affects the expression of G0S2 mRNA CTD PMID:29761207 buspirone increases expression ISO RGD:1311675 6480464 Buspirone results in increased expression of G0S2 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:1604363 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of G0S2 mRNA CTD PMID:29432896 butyric acid decreases expression ISO RGD:1311675 6480464 Butyric Acid results in decreased expression of G0S2 mRNA CTD PMID:12800193 cadmium atom decreases expression ISO RGD:1604363 6480464 Cadmium results in decreased expression of G0S2 mRNA CTD PMID:19716837 , PMID:21120746 cadmium atom increases expression ISO RGD:1604363 6480464 Cadmium results in increased expression of G0S2 mRNA CTD PMID:23369406 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of G0S2 mRNA CTD PMID:24067728 cadmium atom increases methylation ISO RGD:1604363 6480464 Cadmium results in increased methylation of G0S2 promoter CTD PMID:19716837 calcitriol increases expression ISO RGD:1604363 6480464 Calcitriol results in increased expression of G0S2 mRNA CTD PMID:16002434 , PMID:26485663 captan increases expression EXP 6480464 Captan results in increased expression of G0S2 mRNA CTD PMID:31558096 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1604363 6480464 Nanotubes, Carbon results in increased expression of G0S2 mRNA CTD PMID:29348435 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of G0S2 mRNA CTD PMID:25554681 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of G0S2 mRNA CTD PMID:33711761 chloroethene decreases expression EXP 6480464 Vinyl Chloride results in decreased expression of G0S2 mRNA CTD PMID:18579281 chloropicrin decreases expression ISO RGD:1604363 6480464 chloropicrin results in decreased expression of G0S2 mRNA CTD PMID:26352163 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of G0S2 mRNA CTD PMID:23125180 chloroprene decreases expression ISO RGD:1311675 6480464 Chloroprene results in decreased expression of G0S2 mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of G0S2 mRNA CTD PMID:18353800 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of G0S2 mRNA CTD PMID:17585979 clofibric acid multiple interactions ISO RGD:1311675 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of G0S2 mRNA CTD PMID:17602206 cobalt atom multiple interactions ISO RGD:1604363 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of G0S2 mRNA CTD PMID:18078969 cobalt dichloride increases expression ISO RGD:1604363 6480464 cobaltous chloride results in increased expression of G0S2 mRNA CTD PMID:23052192 crocidolite asbestos affects expression ISO RGD:1604363 6480464 Asbestos, Crocidolite affects the expression of G0S2 mRNA CTD PMID:24160326 , PMID:25757056 CU-O LINKAGE decreases expression ISO RGD:1604363 6480464 cupric oxide results in decreased expression of G0S2 mRNA CTD PMID:22077320 cyclosporin A decreases expression ISO RGD:1604363 6480464 Cyclosporine results in decreased expression of G0S2 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1604363 6480464 Cyclosporine results in increased expression of G0S2 mRNA CTD PMID:27989131 , PMID:33631201 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of G0S2 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1604363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of G0S2 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:1604363 6480464 Dexamethasone results in increased expression of G0S2 mRNA CTD PMID:25047013 diarsenic trioxide increases expression ISO RGD:1604363 6480464 Arsenic Trioxide results in increased expression of G0S2 mRNA CTD PMID:29633893 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of G0S2 mRNA CTD PMID:28962523 diethylstilbestrol increases expression ISO RGD:1604363 6480464 Diethylstilbestrol results in increased expression of G0S2 mRNA CTD PMID:19371625 , PMID:22414680 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of G0S2 mRNA CTD PMID:20880076 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of G0S2 mRNA CTD PMID:30529165 dioxygen decreases expression ISO RGD:1604363 6480464 Oxygen deficiency results in decreased expression of G0S2 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:1604363 6480464 Oxygen deficiency inhibits the reaction [darinaparsin results in decreased expression of G0S2 mRNA] CTD PMID:22535156 diuron decreases expression ISO RGD:1311675 6480464 Diuron results in decreased expression of G0S2 mRNA CTD PMID:25152437 diuron increases expression ISO RGD:1311675 6480464 Diuron results in increased expression of G0S2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1604363 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:1604363 6480464 G0S2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 elemental selenium increases expression ISO RGD:1604363 6480464 Selenium results in increased expression of G0S2 mRNA CTD PMID:17293063 endosulfan decreases expression ISO RGD:1311675 6480464 Endosulfan results in decreased expression of G0S2 mRNA CTD PMID:29391264 endosulfan affects expression ISO RGD:1311675 6480464 Endosulfan affects the expression of G0S2 mRNA CTD PMID:29391264 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of G0S2 mRNA CTD PMID:35436446 formaldehyde decreases expression ISO RGD:1604363 6480464 Formaldehyde results in decreased expression of G0S2 mRNA CTD PMID:20655997 , PMID:28937961 formaldehyde increases expression ISO RGD:1604363 6480464 Formaldehyde results in increased expression of G0S2 mRNA CTD PMID:27664576 furan decreases expression ISO RGD:1311675 6480464 furan results in decreased expression of G0S2 mRNA CTD PMID:26194646 genistein increases expression ISO RGD:1604363 6480464 Genistein results in increased expression of G0S2 mRNA CTD PMID:19371625 , PMID:23019147 genistein affects expression ISO RGD:1604363 6480464 Genistein affects the expression of G0S2 mRNA CTD PMID:26865667 griseofulvin decreases expression EXP 6480464 Griseofulvin results in decreased expression of G0S2 mRNA CTD PMID:12735108 hydrogen peroxide affects expression ISO RGD:1604363 6480464 Hydrogen Peroxide affects the expression of G0S2 mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:1604363 6480464 hydroquinone results in increased expression of G0S2 mRNA CTD PMID:31256213 indinavir multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 indometacin multiple interactions ISO RGD:1604363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of G0S2 mRNA CTD PMID:28628672 irinotecan increases expression ISO RGD:1311675 6480464 Irinotecan results in increased expression of G0S2 mRNA CTD PMID:20097248 ketamine decreases expression ISO RGD:1311675 6480464 Ketamine results in decreased expression of G0S2 mRNA CTD PMID:20080153 L-ascorbic acid multiple interactions ISO RGD:1604363 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of G0S2 mRNA CTD PMID:17639512 lamivudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA, [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 leflunomide increases expression ISO RGD:1604363 6480464 leflunomide results in increased expression of G0S2 mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO RGD:1604363 6480464 Lipopolysaccharides results in increased expression of G0S2 mRNA CTD PMID:18192897 , PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1604363 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of G0S2 mRNA CTD PMID:35811015 manganese(II) chloride increases expression ISO RGD:1311675 6480464 manganese chloride results in increased expression of G0S2 mRNA CTD PMID:28801915 menadione affects expression ISO RGD:1604363 6480464 Vitamin K 3 affects the expression of G0S2 mRNA CTD PMID:20044591 mercaptopurine increases expression ISO RGD:1311675 6480464 Mercaptopurine results in increased expression of G0S2 mRNA CTD PMID:23358152 metacetamol decreases expression EXP 6480464 3-hydroxyacetanilide results in decreased expression of G0S2 mRNA CTD PMID:18544908 metformin increases expression ISO RGD:1311675 6480464 Metformin results in increased expression of G0S2 mRNA CTD PMID:31324951 methylparaben decreases expression ISO RGD:1604363 6480464 methylparaben results in decreased expression of G0S2 mRNA CTD PMID:31745603 mitomycin C affects response to substance ISO RGD:1604363 6480464 G0S2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 monosodium L-glutamate multiple interactions EXP 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of G0S2 mRNA CTD PMID:20111022 Muraglitazar increases expression ISO RGD:1311675 6480464 muraglitazar results in increased expression of G0S2 mRNA CTD PMID:21515302 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of G0S2 mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression ISO RGD:1311675 6480464 1-Methyl-4-phenylpyridinium results in increased expression of G0S2 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO RGD:1311675 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of G0S2 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine decreases expression ISO RGD:1311675 6480464 Diethylnitrosamine results in decreased expression of G0S2 mRNA CTD PMID:19638242 N-nitrosodimethylamine decreases expression ISO RGD:1311675 6480464 Dimethylnitrosamine results in decreased expression of G0S2 mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:1604363 6480464 N-Nitrosopyrrolidine results in decreased expression of G0S2 mRNA CTD PMID:32234424 nitrofen increases expression ISO RGD:1311675 6480464 nitrofen results in increased expression of G0S2 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:1604363 6480464 methyleugenol results in decreased expression of G0S2 mRNA CTD PMID:32234424 oxaliplatin multiple interactions ISO RGD:1311675 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of G0S2 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:1311675 6480464 oxaliplatin results in increased expression of G0S2 mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of G0S2 mRNA CTD PMID:12763052 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of G0S2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of G0S2 mRNA CTD PMID:34911549 ozone decreases expression ISO RGD:1311675 6480464 Ozone results in decreased expression of G0S2 mRNA CTD PMID:28623178 paclitaxel increases expression ISO RGD:1311675 6480464 Paclitaxel analog results in increased expression of G0S2 mRNA, Paclitaxel results in increased expression of G0S2 mRNA CTD PMID:15585946 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of G0S2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1604363 6480464 Acetaminophen results in decreased expression of G0S2 mRNA CTD PMID:26690555 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of G0S2 mRNA CTD PMID:18544908 paraquat decreases expression ISO RGD:1311675 6480464 Paraquat results in decreased expression of G0S2 mRNA CTD PMID:32680482 paraquat affects expression ISO RGD:1604363 6480464 Paraquat affects the expression of G0S2 mRNA CTD PMID:34097952 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1604363 6480464 perfluorooctane sulfonic acid results in decreased expression of G0S2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of G0S2 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1604363 6480464 perfluorooctanoic acid results in increased expression of G0S2 mRNA CTD PMID:25868421 perfluorooctanoic acid multiple interactions ISO RGD:1604363 6480464 perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of G0S2 mRNA], Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of G0S2 mRNA]] CTD PMID:31896193 perfluorooctanoic acid increases expression ISO RGD:1311675 6480464 perfluorooctanoic acid results in increased expression of G0S2 mRNA CTD PMID:28511854 phenacetin decreases expression ISO RGD:1311675 6480464 Phenacetin results in decreased expression of G0S2 mRNA CTD PMID:17082564 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of G0S2 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:1604363 6480464 Phenobarbital affects the expression of G0S2 mRNA CTD PMID:19159669 phenobarbital decreases expression ISO RGD:1311675 6480464 Phenobarbital results in decreased expression of G0S2 mRNA CTD PMID:16940010 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of G0S2 mRNA CTD PMID:19482888 phenylhydrazine decreases expression ISO RGD:1311675 6480464 phenylhydrazine results in decreased expression of G0S2 mRNA CTD PMID:17082564 phenylmercury acetate increases expression ISO RGD:1604363 6480464 Phenylmercuric Acetate results in increased expression of G0S2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1604363 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of G0S2 mRNA CTD PMID:27188386 PhIP increases expression ISO RGD:1311675 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of G0S2 mRNA CTD PMID:15215175 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of G0S2 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of G0S2 mRNA] CTD PMID:17950772 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of G0S2 mRNA CTD PMID:17426115 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of G0S2 mRNA CTD PMID:11798191 , PMID:16985257 pirinixic acid decreases expression ISO RGD:1311675 6480464 pirinixic acid results in decreased expression of G0S2 mRNA CTD PMID:19162173 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of G0S2 mRNA CTD PMID:18445702 potassium chromate increases expression ISO RGD:1604363 6480464 potassium chromate(VI) results in increased expression of G0S2 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of G0S2 mRNA CTD PMID:27413110 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of G0S2 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:1604363 6480464 Progesterone results in increased expression of G0S2 mRNA CTD PMID:21795739 progesterone affects expression ISO RGD:1604363 6480464 Progesterone affects the expression of G0S2 mRNA CTD PMID:31896193 progesterone multiple interactions ISO RGD:1604363 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of G0S2 mRNA more ... CTD PMID:20660070 , PMID:31896193 purine-6-thiol increases expression ISO RGD:1311675 6480464 Mercaptopurine results in increased expression of G0S2 mRNA CTD PMID:23358152 quercetin multiple interactions ISO RGD:1604363 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of G0S2 mRNA CTD PMID:17639512 rac-lactic acid increases expression ISO RGD:1604363 6480464 Lactic Acid results in increased expression of G0S2 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1604363 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of G0S2 mRNA CTD PMID:19059307 resveratrol increases expression ISO RGD:1604363 6480464 resveratrol results in increased expression of G0S2 mRNA CTD PMID:17257620 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of G0S2 mRNA] CTD PMID:31298478 ritodrine decreases expression EXP 6480464 Ritodrine results in decreased expression of G0S2 mRNA CTD PMID:23370008 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1604363 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of G0S2 mRNA CTD PMID:35811015 saquinavir multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 SB 431542 multiple interactions ISO RGD:1604363 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1604363 6480464 Selenium results in increased expression of G0S2 mRNA CTD PMID:17293063 senecionine increases expression EXP 6480464 senecionine results in increased expression of G0S2 protein CTD PMID:35357534 serpentine asbestos affects expression ISO RGD:1604363 6480464 Asbestos, Serpentine affects the expression of G0S2 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:1604363 6480464 Silicon Dioxide analog results in increased expression of G0S2 mRNA, Silicon Dioxide results in increased expression of G0S2 mRNA CTD PMID:22300531 more ... sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of G0S2 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:1604363 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of G0S2 mRNA CTD PMID:32525701 sodium arsenite multiple interactions ISO RGD:1604363 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of G0S2 promoter CTD PMID:18448484 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of G0S2 mRNA CTD PMID:33145626 sodium arsenite decreases expression ISO RGD:1604363 6480464 sodium arsenite results in decreased expression of G0S2 mRNA CTD PMID:29301061 sodium dichromate decreases expression ISO RGD:1311675 6480464 sodium bichromate results in decreased expression of G0S2 mRNA CTD PMID:25993096 sodium dodecyl sulfate increases expression ISO RGD:1604363 6480464 Sodium Dodecyl Sulfate results in increased expression of G0S2 mRNA CTD PMID:31734321 sulfasalazine increases expression EXP 6480464 Sulfasalazine results in increased expression of G0S2 mRNA CTD PMID:31830553 sunitinib increases expression ISO RGD:1604363 6480464 Sunitinib results in increased expression of G0S2 mRNA CTD PMID:31533062 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of G0S2 mRNA CTD PMID:25123088 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of G0S2 mRNA CTD PMID:17555576 , PMID:20937368 tamoxifen affects expression ISO RGD:1604363 6480464 Tamoxifen affects the expression of G0S2 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO RGD:1604363 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of G0S2 mRNA, ESR1 protein affects the reaction [Tamoxifen results in increased expression of G0S2 mRNA] CTD PMID:14699072 , PMID:19059307 tert-butyl hydroperoxide increases expression ISO RGD:1604363 6480464 tert-Butylhydroperoxide results in increased expression of G0S2 mRNA CTD PMID:15336504 Tesaglitazar increases expression ISO RGD:1311675 6480464 tesaglitazar results in increased expression of G0S2 mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:1311675 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of G0S2 mRNA CTD PMID:32741896 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of G0S2 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of G0S2 mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide decreases expression ISO RGD:1311675 6480464 Thioacetamide results in decreased expression of G0S2 mRNA CTD PMID:22659510 more ... thioacetamide multiple interactions ISO RGD:1311675 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of G0S2 mRNA CTD PMID:28943392 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of G0S2 mRNA CTD PMID:31298478 titanium dioxide multiple interactions EXP 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of G0S2 mRNA] CTD PMID:31298478 toluene decreases expression ISO RGD:1311675 6480464 Toluene results in decreased expression of G0S2 mRNA CTD PMID:22967744 topotecan increases expression ISO RGD:1311675 6480464 Topotecan results in increased expression of G0S2 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1311675 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of G0S2 mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:1311675 6480464 tributyltin results in increased expression of G0S2 mRNA CTD PMID:21683754 trichloroethene decreases expression ISO RGD:1311675 6480464 Trichloroethylene results in decreased expression of G0S2 mRNA CTD PMID:19448997 trichloroethene increases expression ISO RGD:1311675 6480464 Trichloroethylene results in increased expression of G0S2 mRNA CTD PMID:33387578 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of G0S2 mRNA CTD PMID:25549359 triclosan decreases expression ISO RGD:1604363 6480464 Triclosan results in decreased expression of G0S2 mRNA CTD PMID:30510588 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of G0S2 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1311675 6480464 troglitazone results in increased expression of G0S2 mRNA CTD PMID:21515302 troglitazone decreases expression ISO RGD:1604363 6480464 troglitazone results in decreased expression of G0S2 mRNA CTD PMID:25572481 Tungsten carbide multiple interactions ISO RGD:1604363 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of G0S2 mRNA CTD PMID:18078969 valproic acid decreases expression ISO RGD:1604363 6480464 Valproic Acid results in decreased expression of G0S2 mRNA CTD PMID:29154799 , PMID:29501571 valproic acid multiple interactions ISO RGD:1604363 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of G0S2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1604363 6480464 Valproic Acid results in increased expression of G0S2 mRNA CTD PMID:24383497 more ... vincaleukoblastine affects response to substance ISO RGD:1604363 6480464 G0S2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vitamin E increases expression ISO RGD:1604363 6480464 Vitamin E results in increased expression of G0S2 mRNA CTD PMID:19244175 zearalenone increases expression ISO RGD:1604363 6480464 Zearalenone results in increased expression of G0S2 mRNA CTD PMID:19371625 zidovudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of G0S2 mRNA, [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA CTD PMID:16931933 zinc atom decreases expression ISO RGD:1311675 6480464 Zinc deficiency results in decreased expression of G0S2 mRNA CTD PMID:19111725 zinc atom multiple interactions ISO RGD:1311675 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of G0S2 mRNA] CTD PMID:19111725 zinc(0) decreases expression ISO RGD:1311675 6480464 Zinc deficiency results in decreased expression of G0S2 mRNA CTD PMID:19111725 zinc(0) multiple interactions ISO RGD:1311675 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of G0S2 mRNA] CTD PMID:19111725